Tom patterson was sick. He was in coma for months. In the intensive care unit in the hospital of the university of california in san diego, he could not help him in the spring of 2016 – in any case no antibiotic. His organs began to fail. Because both his blood and his abdominal room were infested by the multi-resistant pathogen acinetobacter baumannii. Also as "iraqibacter" known keim received this nickname because he provided the iraq war in many soldiers for poorly healing wounds. Patterson had recently captured a variant of a variant of a holiday in egypt at the end of 2015. After his return to the california home, it turned out that they were resistant to all antibiotics, including the so-called reserve antibiotics,.
But patterson had enormous gluck. His wife steffanie strathdee is the director of the global health institute of the university in san diego, and she had belonged to a therapy, which can work wonders in such traps: viruses, namely a variant that infested bacteria – so-called bacteriophages. Already discovered a good hundred years ago, they mounted a tremendous potential for the fight against bacterial infections. Because the phages that do not consist of much more than their inheritance material and a hulle drum are specialized in certain bacteria. Your so-called lytic variant (see chart) penetrates into the cells and brings the host to produce as many new phages until it ends up and comes in the end.
For patterson, a phage therapy seemed to be the last chance of rescue. The problem was only: she is almost unsusely untouched in the united states and western europe, there is no general tenant. Strathdee put together with the attending physician robert schooley, a specialist for infectious diseases, all levers in motion to receive permission exceptionally. For gluck, the american researcher community reacted quickly.